Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Market Cap
$17.50M
EBITDA Margin
-23.24%
TTM Avg
-24.75%
3Y Avg
-25.93%
5Y Avg
-17.56%
Market Cap
$17.27M
EBITDA Margin
-30564.79%
TTM Avg
-16005.09%
3Y Avg
-14551.39%
5Y Avg
-13807.79%
Market Cap
$17.14M
EBITDA Margin
-65.27%
TTM Avg
-65.27%
3Y Avg
-407.18%
5Y Avg
-920.02%
Market Cap
$17.07M
EBITDA Margin
-521.61%
TTM Avg
-265.78%
3Y Avg
-984.51%
5Y Avg
-733.51%
Market Cap
$16.84M
EBITDA Margin
-168.69%
TTM Avg
-262.41%
3Y Avg
-983.34%
5Y Avg
-3401.51%
Market Cap
$18.67M
EBITDA Margin
-779.07%
TTM Avg
-389.93%
3Y Avg
-389.93%
5Y Avg
-2320.55%
Market Cap
$16.70M
EBITDA Margin
-82.81%
TTM Avg
-187.23%
3Y Avg
-342.47%
5Y Avg
-369.32%
Market Cap
$16.50M
EBITDA Margin
-1287.62%
TTM Avg
-2964.71%
3Y Avg
-1700.58%
5Y Avg
-1592.26%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | $17.71M | N/A | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $17.50M | -23.24% | -24.75% | -25.93% | -17.56% |
| PAVmed Inc. (PAVM)vs › | $17.27M | -30564.79% | -16005.09% | -14551.39% | -13807.79% |
| Palatin Technologies, Inc. (PTN)vs › | $17.14M | -65.27% | -65.27% | -407.18% | -920.02% |
| Lipocine Inc. (LPCN)vs › | $17.07M | -521.61% | -265.78% | -984.51% | -733.51% |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | -168.69% | -262.41% | -983.34% | -3401.51% |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.67M | -779.07% | -389.93% | -389.93% | -2320.55% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.70M | -82.81% | -187.23% | -342.47% | -369.32% |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.50M | -1287.62% | -2964.71% | -1700.58% | -1592.26% |
| Dyadic International, Inc. (DYAI)vs › | $16.40M | -579.88% | -374.35% | -344.55% | -411.92% |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
